Fundraising Fox

Supersapiens

Defunct

Founded 2019 · 13 employees on LinkedIn · 10 known investors

Supersapiens offers a real-time energy management system for athletes, built in partnership with Abbott using continuous glucose monitoring (CGM) sensor technology. It targets competitive athletes, active-lifestyle enthusiasts, and biohackers who want to monitor and optimize their physical performance.

Also known as TT1 Products, Inc.

Founders & leadership

P
Phil

Investors · 10

Also in the syndicate · 8

Ed BakerEric MinHarvey SchwartzMICA Ventures AGleadMichael HartwegleadRémi DucheminSwiss Startup GroupWahoo Fitness

Company profile

researched Aug 2026

Supersapiens was a sports technology company that built a real-time energy management system for athletes around continuous glucose monitoring (CGM). The product combined the Abbott Libre Sense Glucose Sport Biosensor — a needle-free sensor worn for up to 14 days that streams minute-by-minute glucose data over Bluetooth and can be worn while swimming — with the company's own mobile app, a desktop portal and an accessory wrist device called the Energy Band. The biosensor was positioned as available without a prescription and was intended for athletes to measure glucose rather than for diagnosis, treatment or monitoring of disease.

The software layer provided a live minute-by-minute glucose trace with trend arrow, daily insight summaries, a per-workout "Glucose Score" metric, push notifications when a user trended out of the recovery zone, and a desktop portal for longer-term trend analysis, export and sharing. Integrations covered Garmin and Wahoo devices, TrainingPeaks, Apple Health, Oura and Nolio, allowing glucose data to flow into third-party apps and heart rate, power and pace data to flow into the Supersapiens dashboard. Educational guidance centred on elevating glucose at the right times during exercise and keeping levels between roughly 70 and 140 mg/dL outside exercise for recovery, sleep and weight management.

The company operated as TT1 Products, Inc. and described itself as US-based, with commercial availability restricted to a set of European markets. In February 2024 it informed customers of a strategic restructuring under which sensor shipments stopped, memberships were terminated, and dashboard access and integrations were discontinued.

Founding story

The company traces its origin to founder and CEO Phil Southerland, who worked with Abbott and an all-diabetic professional cycling team over many years on continuous glucose monitoring technology. Once sensors were considered proven and accurate, Supersapiens partnered with Abbott to build what it described as a real-time energy management system for athletes. Todd Furneaux was co-founder and president.

Business model

Direct-to-consumer hardware-plus-software subscription: recurring plans bundled Abbott Libre Sense biosensors, protective Performance Patches and access to the free Supersapiens app, with sensors shipped on a monthly, three-month or six-month cycle. Six-month subscribers also received an Energy Band in their first shipment. Subscriptions renewed automatically and could be cancelled at any time; the company also sold Performance Patches and merchandise separately.

Subscription revenue from biosensor plans priced in euros with VAT and shipping included: €200 per month for two sensors on a one-month plan, €480 billed quarterly (€160/month) for six sensors, and €900 billed every six months (€150/month) for twelve sensors plus an Energy Band. Payments were taken via card, Apple Pay and PayPal, with billing handled through Stripe after a December 2023 platform change.

Traction

More than 2,000 paying athletes in the first 12 weeks after launch (as of April 2021). The website later cited over 32,000 members, more than 4.4 million user-created app events and a 4.5-star App Store rating.

Latest developments

On 29 February 2024 it was reported that Supersapiens had told active members it was undergoing a strategic restructuring: sensor shipments ceased immediately, memberships were terminated, the app would continue to serve historical data for roughly 45-60 days without updates or support, dashboard access would end on 31 March 2024, and all third-party integrations would be discontinued.

Full profile — market position, technology, go-to-market, geography, history, risks & controversies

Market position

At its 2021 raise the company described itself as the global leader in energy management for sports and said its round was the largest investment in the sports CGM space. Its position rested on an exclusive-style partnership with Abbott as the only energy management ecosystem integrating directly with a Bluetooth-enabled sports CGM. Market reach was constrained by the absence of US and Canadian approvals and by the UCI ban on in-competition use.

Direct integration with the Abbott Libre Sense Glucose Sport Biosensor, which provided minute-by-minute rather than intermittent glucose data and required no prescription; a proprietary software layer with real-time guidance, a workout Glucose Score and coach-facing desktop analytics; and the Energy Band, which paired directly with the sensor over Bluetooth so no phone was needed.

Technology

Abbott's Libre Sense sport biosensor uses a small filament inserted in the arm, is worn continuously for up to 14 days, is water-resistant enough for swimming and streams glucose readings via Bluetooth. Supersapiens layered mobile and web applications on top, delivering live traces, event logging, alerts, exports and API-style integrations with Garmin, Wahoo, TrainingPeaks, Apple Health, Oura and Nolio. Reported constraints included a roughly 10-15 minute lag between nutrition intake and glucose readings, Abbott-imposed connectivity restrictions that required a phone for some integrations, and adhesive wear from swimming and frequent showering.

Go-to-market

Online direct sales through supersapiens.com with country-gated checkout, subscription waitlists during stock shortages, a sales team for enquiries, and content marketing via a blog, downloadable glucose guide and education hub. Visibility was built through endorsements and use by high-profile athletes and teams, including Eliud Kipchoge, Team Jumbo-Visma, Lisa Norden, Petter Engdahl and Jan Frodeno, alongside partner brands in cycling and fitness hardware.

Endurance and competitive athletes plus active-lifestyle users: triathletes, cyclists, runners, trail runners, skiers and Hyrox athletes, as well as amateur athletes and self-experimenters focused on fuelling, recovery, sleep and weight management. Coaches and medical practitioners also used the desktop portal for collaboration. The product was aimed particularly at workouts of 90 minutes or longer at steady state.

Geography

Headquartered in Atlanta, Georgia, and described as a US-based company, with sales limited to Austria, France, Germany, Ireland, Italy, Luxembourg, Switzerland and the United Kingdom. The product was not approved for sale in the United States or Canada.

History

Supersapiens launched its ecosystem in late 2020 in Europe and reported more than 2,000 paying athletes within its first 12 weeks on the market. In April 2021 it announced a $13.5 million early-stage raise led by MICA Ventures AG and was developing its first hardware product, a wrist wearable then called the Supersapiens Reader Version Zero, later marketed as the Energy Band. The company never obtained approvals to sell to customers in the United States or Canada, and use of its product was banned in UCI cycling competition. In February 2024 it announced a strategic restructuring that ended sensor shipments and memberships, with dashboard access closing on 31 March 2024.

Risks & controversies

The company was unable to secure regulatory approval to sell in the US and Canada, restricting it to a smaller European market, and the UCI banned use of the product in competition, limiting pro cycling exposure. Independent testing raised questions about the interpretability of the data for some users and about practical issues such as sensor adhesion during swimming and the battery drain of the wrist accessory. The 2024 wind-down left customers with limited historical data access, no refunds policy for biosensors and discontinued integrations.

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
App Store ratingJan 20244.5 stars
MembersJan 202432,000 members
Paying athletesApr 20212,000 customers
Subscription price (1-month plan)Jan 2024200 EUR/month
Subscription price (6-month plan)Jan 2024150 EUR/month
User-created app eventsJan 20244,417,915 events

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Timeline · 6

launches, deals, and filings
Feb 2024
No US or Canadian approvals; UCI banned in-competition use

Supersapiens never obtained approvals to operate with customers in the US or Canada, limiting it to European markets, and the UCI banned use of the product in competition.

source ↗

Feb 2024
Supersapiens announces strategic restructuring and service closure

Customers were told sensor shipments had ceased immediately and memberships were terminated; the app would retain historical data access for about 45-60 days without support, dashboard access would end 31 March 2024, and all third-party integrations would be discontinued.

source ↗

Apr 2021
Supersapiens closes $13.5M early-stage round led by MICA Ventures AG

Announced a $13.5 million capital raise led by MICA Ventures AG founder Michael Hartweg, with participation from Ed Baker, Harvey Schwartz, Rémi Duchemin, Eric Min, CM Ventures, Rubix Ventures, Swiss Startup Group and Wahoo Fitness.

$13.5M source ↗

Apr 2021
Partnership with Abbott around Libre Sense Glucose Sport Biosensor

Supersapiens' ecosystem integrated directly with Abbott's Bluetooth-enabled Libre Sense Glucose Sport Biosensor, the basis of its athlete-facing energy management system.

source ↗

Apr 2021
First hardware product in development: Supersapiens Reader Version Zero

The company disclosed work on a wrist wearable, the Supersapiens Reader Version Zero, to display live-streaming glucose data at a glance.

source ↗

Jan 2020
Supersapiens ecosystem launches in Europe

The Supersapiens system powered by Abbott Libre Sense launched in late 2020 and was available in Austria, France, Germany, Ireland, Italy, Luxembourg, Switzerland and the United Kingdom.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

Research sources · 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Supersapiens do?
Supersapiens sold a subscription glucose-monitoring system for athletes built on Abbott's Libre Sense sport biosensor; it wound down in 2024.
Who are Supersapiens's investors?
Supersapiens's investors include CM Ventures, Vibe Capital.